MedPath

QILU PHARMA SPAIN SL.

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

44

CIMA_AEMPS:42
EMA:2

Drug Approvals

Rimmyrah

Authorization Status
Authorised
Approval Date
Jan 5, 2024
EMA

Rimmyrah

Authorization Status
Authorised
Approval Date
Jan 5, 2024
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.